Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for Early Stage SARS-CoV-2 (STORM)
NCT04433078Phase 2Withdrawn
- Sponsor
- Temple University
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in coronavirus disease 2019 (COVID-19), sponsored by Temple University. Planned start Jun 2020; status: withdrawn.
02
Drugs
doxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04433078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433078.